Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    3.

    Implementation of treatment protocols in the Diabetes Control and Complications Trial.

    [No authors listed]

    Diabetes Care. 1995 Mar;18(3):361-76.PMID: 7555480 [PubMed - indexed for MEDLINE]Related articles

    4.

    Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

    Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

    Diabetes Care. 1995 Aug;18(8):1113-23.PMID: 7587846 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.

    Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD.

    JAMA. 1998 Jul 8;280(2):140-6. Erratum in: JAMA 1998 Nov 4;280(17):1484. PMID: 9669786 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.

    Sinha A, Formica C, Tsalamandris C, Panagiotopoulos S, Hendrich E, DeLuise M, Seeman E, Jerums G.

    Diabet Med. 1996 Jan;13(1):40-6.PMID: 8741811 [PubMed - indexed for MEDLINE]Related articles

    7.

    Body composition in adults with Type 1 diabetes at onset and during the first year of insulin therapy.

    Rosenfalck AM, Almdal T, Hilsted J, Madsbad S.

    Diabet Med. 2002 May;19(5):417-23.PMID: 12027931 [PubMed - indexed for MEDLINE]Related articles

    8.

    Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.

    Hathout EH, McClintock T, Sharkey J, Kytsenko D, Hartwick N, Hadley-Scofield M, Torgeson S, Mace JW.

    Diabetes Technol Ther. 2003;5(2):175-81.PMID: 12871607 [PubMed - indexed for MEDLINE]Related articles

    9.

    Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group.

    [No authors listed]

    Diabetes Care. 1988 Jul-Aug;11(7):567-73.PMID: 2904881 [PubMed - indexed for MEDLINE]Related articles

    11.

    Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy.

    Palmer AJ, Roze S, Valentine WJ, Minshall ME, Lammert M, Nicklasson L, Spinas GA.

    Curr Med Res Opin. 2004 Aug;20 Suppl 1:S67-73.PMID: 15324518 [PubMed - indexed for MEDLINE]Related articles

    12.

    A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

    DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

    Diabetes Care. 2002 Nov;25(11):2074-80.PMID: 12401759 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.

    Tong PC, Lee ZS, Sea MM, Chow CC, Ko GT, Chan WB, So WY, Ma RC, Ozaki R, Woo J, Cockram CS, Chan JC.

    Arch Intern Med. 2002 Nov 25;162(21):2428-35.PMID: 12437401 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial.

    Delahanty LM, Nathan DM, Lachin JM, Hu FB, Cleary PA, Ziegler GK, Wylie-Rosett J, Wexler DJ; Diabetes Control and Complications Trial/Epidemiology of Diabetes.

    Am J Clin Nutr. 2009 Feb;89(2):518-24. Epub 2008 Dec 23.PMID: 19106241 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    'Glucose control-related' and 'non-glucose control-related' effects of insulin on weight gain in newly insulin-treated type 2 diabetic patients.

    Sallé A, Ryan M, Guilloteau G, Bouhanick B, Berrut G, Ritz P.

    Br J Nutr. 2005 Dec;94(6):931-7.PMID: 16351770 [PubMed - indexed for MEDLINE]Related articles

    16.

    The use of bioelectrical impedance analysis (BIA) to estimate body composition in the Diabetes Control and Complications Trial (DCCT).

    Leiter LA, Lukaski HC, Kenny DJ, Barnie A, Camelon K, Ferguson RS, MacLean S, Simkins S, Zinman B, Cleary PA.

    Int J Obes Relat Metab Disord. 1994 Dec;18(12):829-35.PMID: 7894522 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.

    Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.

    Circulation. 2005 May 17;111(19):2446-53. Epub 2005 May 2.PMID: 15867184 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.

    Soliman AT, Omar M, Assem HM, Nasr IS, Rizk MM, El Matary W, El Alaily RK.

    Metabolism. 2002 Mar;51(3):292-6.PMID: 11887162 [PubMed - indexed for MEDLINE]Related articles

    20.

    Potential causes of weight gain in type 1 diabetes mellitus.

    Jacob AN, Salinas K, Adams-Huet B, Raskin P.

    Diabetes Obes Metab. 2006 Jul;8(4):404-11. Erratum in: Diabetes Obes Metab. 2006 Jul;8(4):472. PMID: 16776747 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data